Book a demo
Research & KnowledgeEvent: September 7, 2026

Mayo Clinic Laboratories developed its first-in-class genome-wide methylation array analysis to improve diagnostic accuracy for CNS tumors.

Published

Signal category

Research & Knowledge

Quote

Mayo Clinic Laboratories’ first-in-class genome-wide methylation array analysis improves diagnostic accuracy for these tumors.

Mayo Clinic Laboratories team

Company

Industry
Hospitals and Health Care
Location
Rochester, US
Company size
748 employees

As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic. - 4.5 million patients worldwide - 3,000 plus tests and pathology services - 24 million tests performed annually - 4,500 physicians and scientists at Mayo Clinic - 90 plus subspecialty pathologists - 560 peer-reviewed articles published annually

Founded 1971

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.